Us Consumer Should Not Continue to Fund Protection for Us
- Finance
- Watchlists
- My Portfolio
- Cryptocurrencies
- Yahoo Finance Plus
- News
- Screeners
- Markets
- Options: Highest Open Interest
- Options: Highest Implied Volatility
-
- Personal Finance
- Videos
- Influencers with Andy Serwer
- America: Back in Business
-
- All Markets Summit
- Yahoo U
- Industries
- Tech
- Contact Us
-
S&P 500
-
Dow 30
-
Nasdaq
-
Russell 2000
-
Crude Oil
-
Gold
-
Silver
-
EUR/USD
-
10-Yr Bond
-
GBP/USD
-
USD/JPY
-
BTC-USD
-
CMC Crypto 200
-
FTSE 100
-
Nikkei 225
-
Vaxcyte's stock rallies 46% on positive data for its pneumococcal vaccine candidate
Shares of Vaxcyte Inc. soared 46.7% in premarket trading on Monday after the company said its experimental 24-valent pneumococcal conjugate vaccine met the primary endpoint in a Phase 1/2 clinical proof-of-concept study. The vaccine was tested in healthy adults. The company said it plans to advance its vaccine candidate into Phase 3 clinical trials using a 2.2 microgram dose. Vaxcyte's stock is down 13.5% this year, while the S&P 500 has declined 21.2%.
-
Better Buy: Verizon or AT&T?
In this video, I will compare AT&T (NYSE: T) to Verizon Communications (NYSE: VZ) and see which one you should invest in. Both companies pay an over 7% dividend yield, which is very attractive, especially during a bear market.
-
IBM (NYSE:IBM): A Cash Generating Machine Showing Tentative Signs of Growth
Investors have been waiting for 10 years for IBM's turnaround strategy to show up as actual revenue growth. During that decade, annual revenue dwindled from $100 billion to $54 billion in 2020. It's understandable that investors have become skeptical of a few good quarters of improving growth. Nevertheless, it's worth noting that trailing 12-month revenue has now increased for four consecutive quarters.
-
7 Top Stocks That Can Make You Richer in 2023
The widely followed Dow Jones Industrial Average, benchmark S&P 500, and growth stock-driven Nasdaq Composite have all spiraled into a bear market, with these respective indexes falling between 22% and 38% at their peaks.
-
Jefferies Says Now Is the Right Time to Buy Natural Gas Stocks; Here Are 2 Names to Consider
For stock market watchers, 2022 will be remembered as the year of the bear. Going by year-to-date performance, the major indexes are likely to see out 2022 posting negative returns. The same, however, cannot be said for natural gas stocks, which driven by the macro conditions – namely Russia's invasion of Ukraine - have delivered excellent returns for investors, even accounting for the segment's recent pullback. Looking at the prospects of the U.S.'s natural gas sector, Jefferies' Lloyd Byrne th
-
Chinese Markets Tumble as Xi's Tightening Grip Alarms Investors
(Bloomberg) -- China's yuan weakened and country's stocks tumbled to the lowest level since the depths of the 2008 global financial crisis in Hong Kong, a stark rebuke of President Xi Jinping's move to stack his leadership ranks with loyalists.Most Read from BloombergChina Stocks Slide as Leadership Overhaul Disappoints TradersWall Street Is Heading to Saudi Arabia as US Oil Spat SimmersSunak Edges Closer to UK Leadership as Johnson Drops OutKorean Air Plane Overruns Runway While Landing in Phil
valentinesaftessithe.blogspot.com
Source: https://finance.yahoo.com/news/us-consumer-sentiment-stays-weak-110011967.html
0 Response to "Us Consumer Should Not Continue to Fund Protection for Us"
Post a Comment